February 28, 2005
Multiple Sclerosis Drug Tysabri Pulled Off MarketTopics: Clinical Pharmacology
Biogen Idec and Elan announced Monday they have voluntarily withdrawn Tysabri, a drug used to treat multiple sclerosis, after one patient died and another developed a serious disease of the central nervous system after taking it in combination with Avonex for more than two years.
Hat tip - Corante, with more commentary.
Posted by Hyscience at February 28, 2005 1:50 PM
Hat tip to you for your previous post in January where you suggested that Tysabri should have been in clinical trials longer.
Posted by: Zack (Brain Waves) at February 28, 2005 3:37 PM
Articles Related to Clinical Pharmacology:
- Multiple Sclerosis Drug Tysabri Pulled Off Market - Feb 28, 2005